Autologous plasma versus fetal calf serum as a supplement for the culture of neutrophils.
Apoptosis
Autologous plasma
Fetal calf serum
Granulocytes
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
22 Jan 2020
22 Jan 2020
Historique:
received:
04
08
2019
accepted:
09
01
2020
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
23
10
2020
Statut:
epublish
Résumé
Currently, the replacement of fetal calf serum (FCS) by a more suitable alternative is a sought aim in the field of tissue and cell culture research. Autologous plasma (AP) and especially autologous serum (AS) have been shown to be effective substitutes of FCS in culture media for some of the cell types. Nevertheless, there is no comparative data on the most appropriate supplement for cell media in neutrophil studies, it is now unclear whether AP have a relatively equal, superior or inferior performance to FCS in neutrophil cell culture. In the present study, human blood neutrophils were isolated and cultured in FCS- or AP-supplemented medium. After 12, 36 and 60 h of incubation, cell viability, oxidative burst and CD11b expression were determined by flow cytometry. Compared to the culture of neutrophils in FCS 10% medium, the culture of neutrophils in a medium with AP 10% could prolong their life span without affecting their function. The findings introduce AP as a better supplement for human neutrophil cell culture than FCS and propose a simple and economical procedure for neutrophil isolation and culture.
Identifiants
pubmed: 31969182
doi: 10.1186/s13104-020-4902-z
pii: 10.1186/s13104-020-4902-z
pmc: PMC6977324
doi:
Substances chimiques
CD11b Antigen
0
Culture Media
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
39Références
Dev Biol Stand. 1999;99:3-8
pubmed: 10404869
J Transl Med. 2006 Oct 04;4:40
pubmed: 17020621
Am J Hematol. 2008 Apr;83(4):288-95
pubmed: 17924549
Front Physiol. 2018 Feb 20;9:113
pubmed: 29515456
ScientificWorldJournal. 2002 May 21;2:1393-6
pubmed: 12805923
Stem Cell Res Ther. 2019 Mar 7;10(1):79
pubmed: 30845980
J Tissue Eng Regen Med. 2007 Nov-Dec;1(6):436-42
pubmed: 18265417
Front Bioeng Biotechnol. 2017 Nov 20;5:66
pubmed: 29209609
Br J Ophthalmol. 2005 Jun;89(6):748-52
pubmed: 15923513
Expert Rev Proteomics. 2007 Jun;4(3):363-70
pubmed: 17552920
Stem Cell Res Ther. 2018 May 2;9(1):128
pubmed: 29720259
N Biotechnol. 2015 Jan 25;32(1):199-211
pubmed: 24929129
J Immunol Methods. 1985 Oct 10;82(2):315-20
pubmed: 2995497
PLoS One. 2012;7(11):e50542
pubmed: 23209773
AAPS J. 2011 Dec;13(4):632-49
pubmed: 21971647
Curr Protoc Immunol. 2015 Nov 02;111:7.23.1-7.23.16
pubmed: 26528633
Nature. 2016 Sep 14;537(7620):433-5
pubmed: 27629646
Blood. 2016 Aug 18;128(7):993-1002
pubmed: 27402974
Cytotherapy. 2007;9(1):91-8
pubmed: 17354104
Arthritis Rheum. 2008 Feb;58(2):501-10
pubmed: 18240254
J Orthop Surg (Hong Kong). 2008 Aug;16(2):220-9
pubmed: 18725677
Brain. 2011 Jun;134(Pt 6):1790-807
pubmed: 21493695
J Immunol. 1995 Apr 15;154(8):4133-41
pubmed: 7706750
Cell Tissue Bank. 2013 Sep;14(3):413-22
pubmed: 22972165
Cell Biochem Funct. 2000 Jun;18(2):127-32
pubmed: 10814971
N Engl J Med. 1998 Dec 31;339(27):1994-2004
pubmed: 9869672
Altern Lab Anim. 2014 Jun;42(3):207-9
pubmed: 25068932
Clin Oral Investig. 2019 May;23(5):2455-2463
pubmed: 30311062
J Cell Mol Med. 2014 Apr;18(4):624-34
pubmed: 24444305
ALTEX. 2018;35(1):99-118
pubmed: 28800376
Int J Ophthalmol. 2017 Jun 18;10(6):908-913
pubmed: 28730081